What is the recommended distance of the subdermal etonorgestrel implant from the olecranon process upon insertion?

Recommended Distance for Etonogestrel Implant Insertion

The etonogestrel subdermal implant should be inserted 6 to 8 cm (approximately 8-10 cm in some guidelines) above the elbow (medial epicondyle of the humerus) on the inner side of the non-dominant upper arm. 1

Precise Anatomical Placement

The insertion site should be:

• 6-8 cm proximal to the medial epicondyle of the humerus (the bony prominence at the elbow) 1
• On the inner (medial) aspect of the non-dominant upper arm
• 3-5 cm posterior to the groove between the biceps and triceps muscles 2
• Positioned subdermally over the triceps muscle area, not deep into muscle tissue

Critical Safety Considerations

Why This Distance Matters

The specific distance from the olecranon process (elbow) is crucial to avoid neurovascular structures, particularly:

• The ulnar nerve, which runs along the medial aspect of the arm
• The brachial artery and associated vessels
• Deep muscular structures

Recent insertion guidelines emphasize superficial placement to minimize risk of insertion into vessels and nerves 3. Even with proper technique, rare complications like ulnar neuropathy have been reported, though these can occur even with correct superficial placement due to anatomical variations 2.

Common Pitfalls to Avoid

1. Too deep insertion: Inserting below the subdermis into muscle increases risk of nerve injury and device migration 3, 2
2. Too close to the elbow: Increases proximity to neurovascular bundles
3. Incorrect anatomical landmarks: Failure to properly identify the medial epicondyle can lead to misplacement

Clinical Implications

• Insertion takes approximately 1 minute when performed correctly 1
• Removal can be accomplished in under 5 minutes 1
• The implant remains effective for 3 years 1, 4
• Complications are rare but include transient nerve injury and need for removal under general anesthesia 1

Verification of Placement

After insertion, the implant should be:

• Palpable at the insertion site
• If impalpable, imaging (chest X-ray, CT) may be needed to locate migrated devices 3
• Migration beyond 2 cm from insertion site is rarely reported but can occur 3

The 6-8 cm distance from the medial epicondyle represents the optimal balance between effective subdermal placement and avoidance of deeper neurovascular structures, ensuring both contraceptive efficacy and patient safety.